loader
Please Wait
Applying Filters...

List of Carvedilol Active Pharmaceutical Ingredient (API) suppliers/manufacturers & exporters

Menu
$ API Ref.Price (USD/KG) : 294Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Polpharma

02 1Inke S.A

03 1DKSH

04 1Egis Pharmaceuticals PLC

05 1Gonane Pharma

06 1Jai Radhe Sales

07 1Moehs Iberica

08 1HRV Global Life Sciences

09 1Sigmak Lifesciences

10 1Tenatra Chemie

11 1Zeon Pharma Industries India Pvt Ltd

12 1Amara Labs

13 1Anugraha Chemicals

14 1Aurobindo Pharma Limited

15 1Bazayan & Co

16 1CTX Lifesciences

17 1Cadila Pharmaceuticals

18 1Cipla

19 1DEAFARMA

20 1Danesh Kimia Pharmed

21 1Dr. Raju’s Pharma Solutions

22 1Guangzhou Tosun Pharmaceutical

23 1Hermes Chemical

24 1Hoventa Pharma

25 1ITALTECNO

26 1Ipca Laboratories

27 1Nishchem International Pvt. Ltd

28 1Pellsys Pharma

29 1Raks Pharma

30 1Shodhana Laboratories Pvt. Ltd

31 1Suvan Lifesciences

32 1Symed Labs

33 1Synergene Active Ingredients Pvt Ltd

34 1Teva Pharmaceutical Industries

35 1Unipex

36 1Viatris

37 1Zhejiang Huahai Pharmaceutical

38 1Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Polpharma

Poland
arrow
AllPack Indonesia 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Carvedilol

About the Company : Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the c...

Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Production of HPAPI with an OEL value of 10 ng/m3 (OEB 6). The HP API investment includes separate process laboratories (PDL), analytical laboratories (ADL) with the possibility of performing QC analyses, and a GMP kilo-lab production line with volume up to 1.5 kg with potential volume increase.
Polpharma CB